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Synopsis
The formation of amyloid aggregates is the hallmark of systemic and neurodegenerative disorders, also known as
amyloidoses. Many proteins have been found to aggregate into amyloid-like fibrils and this process is recognized as
a general tendency of polypeptides. Lysozyme, an antibacterial protein, is a well-studied model since it is associated
in human with systemic amyloidosis and that is widely available from chicken eggs (HEWL, hen egg white lysozyme).
In the present study we investigated the mechanism of interaction of aggregating HEWL with rosmarinic acid and
resveratrol, that we verified to be effective and ineffective, respectively, in inhibiting aggregate formation. We used a
multidisciplinary strategy to characterize such effects, combining biochemical and biophysical methods with molecular
dynamics (MD) simulations on the HEWL peptide 49–64 to gain insights into the mechanisms and energy variations
associated to amyloid formation and inhibition. MD revealed that neither resveratrol nor rosmarinic acid were able
to compete with the initial formation of the β -sheet structure. We then tested the association of two β -sheets,
representing the model of an amyloid core structure. MD showed that rosmarinic acid displayed an interaction energy
and a contact map comparable to that of sheet pairings. On the contrary, resveratrol association energy was found
to be much lower and its contact map largely different than that of sheet pairings. The overall characterization
elucidated a possible mechanism explaining why, in this model, resveratrol is inactive in blocking fibril formation,
whereas rosmarinic acid is instead a powerful inhibitor.
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INTRODUCTION
Amyloid aggregation can be described as a degenerative process
characterized by the deposition at tissue levels of organized insol-
uble super-molecular protein assemblies with a typical cross-β
secondary structure. Such degeneration give rise to amyloidoses,
a composite range of diseases classically divided into neurode-
generative (e.g. Alzheimer’s disease, Parkinson’s disease, etc.)
and systemic (e.g. cystic fibrosis, light chain amyloidosis). More
than 20 different human proteins, intact, mutated or fragmented,
proved their amyloidogenicity in vivo, among which Aβ-peptide
(in Alzheimer’s disease), α-synuclein (in Parkinson’s disease), is-
let amyloid polypeptide (in type 2 diabetes), β2-microglobulin (in
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dialysis-related amyloidosis), light chains of immunoglobulins or
variants of human lysozyme [1,2]. It is nowadays widely accep-
ted that amyloid aggregation is a general tendency of polypeptide
chains [3–5] that, in fact, may be induced to form amyloid ag-
gregation in appropriate conditions [6].
Lysozyme, a 130 residues long antibacterial enzyme widely
distributed in different tissues, organs and external secretions,
has been highlighted as an interesting model for the study of
amyloid aggregation. Although wild-type lysozyme is not dir-
ectly involved in amyloid diseases [7], several naturally occurring
mutants (e.g. Ile56Thr, Phe57Ile, Trp64Arg and Asp67His) are
connected with familial non-neuropathic systemic amyloidoses
[8]. In addition, wild type lysozyme either from human, horse
or chicken, under favourable conditions, is able to form amyloid
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 1 Rosmarinic acid inhibits amyloid-like aggregation of HEWL and HEWL 49–64 peptide
Column 1: Structures of rosmarinic acid, resveratrol and HEWL (taken from PDB 2VB1). In the latter, the α-domain (top)
and the β -domain (bottom) where the 49–64 peptide is located (highlighted in dark grey) are shown. Columns 2–5, top
row: effect of rosmarinic acid and resveratrol on full-length HEWL. (A) Aggregation kinetic followed by ThT fluorescence
at 485 nm. (B) CR assay at 300 h aggregation (ThT plateau). (C) AFM image (10 μm × 10 μm) of HEWL after 300 h
aggregation. (D) AFM image (10 μm × 10 μm) of HEWL incubated with rosmarinic acid after 300 h aggregation. Columns
2–5, bottom row: effect of rosmarinic acid and resveratrol on 49–64 HEWL peptide. (E) Aggregation kinetic followed by
ThT fluorescence at 485 nm. (F) CR assay at 30 h aggregation (ThT plateau). (G) AFM image (10 μm × 10 μm) of HEWL
peptide after 30 h aggregation. (H) AFM image (10 μm × 10 μm) of HEWL peptide incubated with rosmarinic acid after
300 h aggregation. In (A) and (E) error bars represent S.D. of at least three independent experiments. Other panels show
representative images of the corresponding experiments.
fibrils in vitro [9–11]. In this work we used the hen egg white
lysozyme (HEWL – 14.3 kDa, 129 amino acids, 40 % identity
with the human form, fold α + β, see Figure 1), that has been
shown to undergo amyloid-like aggregation through a heat treat-
ment in acidic conditions [12]. It has been demonstrated that high
temperatures and low pH induce the breakage of X-Asp peptide
bonds, leading to the formation of peptide fragments with a high
tendency to form amyloid aggregates [11] and amyloid-like fib-
rils within few days after the initial exposure. In addition, it has
been demonstrated a direct toxic effect of HEWL aggregates ad-
ded to cell cultures or injected in rat brains, mimicking the toxic
effect of Aβ-peptide [13]. Previous studies on HEWL aggrega-
tion identified that, among the peptide segments involved in the
formation of amyloid-like cores after fragmentation, the peptide
49–64 (originally located in the β-domain, see Figure 1) is par-
ticularly prone to aggregation even in mild conditions [11]. In
fact, the aggregation kinetic of HEWL peptide 49–64 (herein-
after simply HEWL peptide) shows a single exponential shape,
reaching a plateau in 15–20 h and lacks a lag phase, indicating
that amyloid seeds are present since the earliest moment of ag-
gregation. A shorter region within such peptide (54–62, called
peptide K) has been widely investigated in order to identify the
determinants of amyloidogenicity [14]. The Trp residue in posi-
tion 62 was found to be fundamental, preceded by a stretch con-
taining hydrophobic residues. More recently, this hydrophobic
stretch was further identified as having sequence IFQINS in hu-
man lysozyme, and it was shown that it could spontaneously self-
assemble into amyloid-like fibrils, whose structure was determ-
ined by crystallography [15]. All the reported studies demonstrate
that HEWL is an established optimal model system for studying
amyloid.
In this work we approached the topic of amyloid assembly and
inhibition using molecular dynamics (MD). Our strategy was in
part inspired by the recent work of Zhang et al. [16] that studied
the interaction of β-sheets in IAPP by juxtaposing units and
evaluating the energies and most favourable poses by MD. MD
is widely used in drug design and, although admittedly limited
due to the number of chemical approximations needed to operate
calculations in a reasonable time [17], it offers the possibility
of simulating the motion of molecules in force fields, that guide
the energetic relationships among atoms and in turn evaluate the
energy of a system or part of it. Importantly, MD treats every
functional group (e.g. protein side chains or even backbones)
or ligand as a dynamic element able to move in a constrained
environment and therefore establish chemical and geometrical
adaptations. From a chemical perspective, and based on recent
trends, MD surpasses classical docking strategies and represents
one of the most innovative tools in drug design [18].
A huge body of literature have documented that herbal extracts
or common dietary elements such as wine [19] or green-tea [20]
are of great benefit to general human health, mainly due to their
antioxidant power [21,22]. Among the molecules proposed to be
essential for achieving such effects there are polyphenols [23], a
wide and heterogeneous group of substances well characterized
in terms of structure [24] and beneficial properties. Besides pro-
tecting cells from oxidative stress, several phenolic compounds
recently proved to be effective in inhibiting amyloid aggrega-
tion in various disease-related proteins such as α-synuclein, Aβ
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peptide, IAPP or transthyretin, with proposed specific ac-
tion mechanisms independent on their antioxidant properties
[25–28].
In this work we started from preliminary (unpublished data
from the same authors) studies on HEWL amyloid inhibition by
a battery of polyphenols representative of several different classes
and we selected two well-known polyphenols, namely resveratrol
(a typical stilbenoid of grapes and wine) and rosmarinic acid (the
main aromatic compound of culinary herbs such as basil, sage
and, more representatively, rosemary), as candidate molecules
for the present study. In fact, using HEWL and HEWL 49–64
peptide (hereinafter simply HEWL peptide) as model systems of
amyloid, we found that the latter was an effective anti-aggregation
compound, as in other amyloid systems [29–32], whereas the
former did not interfere at all with such process, contrarily to
what observed in other systems, the most noticeable being the
Aβ peptide [25,33,34]. In addition, these two polyphenols proved
not to interfere with the Thioflavin-T (ThT) assay, that is not so
frequent due to the limited solubility and the competitive effects
with ThT of many polyphenolic compounds.
MD on a putative, energetically coherent reconstructed amyl-
oid core of the HEWL peptide was eventually applied to high-
light a possible mechanism leading to amyloid hampering by
polyphenols and explain the experimental results.
MATERIALS AND METHODS
Materials
Reagents and chemicals, unless otherwise specified, were pur-
chased from Sigma–Aldrich and used without further purifica-
tion. Sigma–Aldrich also provided both the HEWL (code L6876)
and the HEWL 49–64 peptide that was synthesized with purity
>80 % (ESI mass 1883 +− 0.1 Da). This peptide had the same se-
quence as residues 49–64 of HEWL (GSTDYGILQINSRWWC),
with the exception of last cysteine residue (C64 in HEWL) that
was changed to serine to prevent disulfide bond formation as it
occurs in the native protein [35]. Resveratrol and rosmarinic acid
were from Extrasynthese.
Aggregation conditions
To achieve a complete amyloid-like aggregation, full length
HEWL or HEWL peptide at a concentration of 1 mM were in-
cubated at 65 ◦C in 10 mM HCl solutions (pH 2.0). Aggregation
time (time to achieve a plateau, according to ThT measurements)
was up to 10 days and 20–30 h, for full length HEWL or HEWL
peptide respectively [35]. Polyphenols were dissolved in DMSO
at 100 mM and added at 1:1 molar ratio to freshly dissolved
HEWL or HEWL peptide. Control aggregation tests for both
HEWL and HEWL peptide were also performed in presence of
1–5 % v/v DMSO in order to exclude possible effects of DMSO
on aggregation.
Thioflavin-T assay
Aggregation kinetics was monitored by ThT assay [36]. For
each measurement session, 0.25 mM ThT was freshly prepared
from 25 mM stock solutions in 25 mM sodium phosphate buf-
fer, pH 6.0. 495 μl of the 1:100 diluted ThT solution were added
to a sample volume of 5 μl. ThT fluorescence was measured at
25 ◦C in a 0.1 cm path quartz cuvette (Hellma) on a RF-5000
fluorimeter (Shimadzu) using 440 nm (5 nm slit) and 485 nm
(5 nm slit) as excitation and emission wavelength respectively.
A baseline measurement of fresh 100-fold diluted stock solution
of ThT incubated with the HCl solutions alone or in presence
of variable amounts of polyphenols at 10 μM concentration was
used to correct sample signals.
ThT fluorescence measurements of aggregation kinetics on
HEWL, both alone or in the presence of polyphenols and DMSO,
were normalized to signals at 300 h and used to extrapolate a plat-
eau signal thanks to a non-linear curve fitting using the eqn (1)
F = Ai + (Af − Ai)/(l + exp((t1/2 − t)kagg)) (1)
where F was the normalized fluorescence, Ai was the initial fluor-
escence, Af the final fluorescence at plateau, t the incubation time,
t1/2 the mid-point of aggregation and kagg the apparent aggrega-
tion rate constant [37]. When polyphenols were added, the plateau
values (F) were then used to calculate the percentage of inhibition
with respect to HEWL control.
Similarly to HEWL, the HEWL peptide ThT fluorescence
signals were normalized at 30 h and fitted to a mono-exponential
curve using the equation (2)
F = A − A exp(−kaggt) (2)
where F was the normalized fluorescence, A was the total fluor-
escence, t the incubation time and kagg the apparent aggregation
rate constant.
Congo red assay
For Congo red (CR) binding assays [38], a 50 mM CR solu-
tion was freshly prepared in 5 mM sodium phosphate buffer at
pH 7.4 containing 150 mM NaCl and filtered through a 0.2-μm
filter. Prior to use, CR solution was diluted 50-fold in the same
buffer. Absorption spectra (400–700 nm) were recorder for (A)
the buffer alone, (B) 440 μl buffer plus 60 μl aggregate solu-
tion, (C) 440 μl CR solution plus 60 μl HCl solution and (D)
440 μl CR solution plus 60 μl fibril solution. All these spec-
tra were background-corrected by subtracting A and the dif-
ference spectra were calculated according to R = D − C −
B. Samples were considered to contain amyloid material if the
resulting difference spectra showed a peak at 540 nm, indicat-
ing a red shift typical of amyloid-bound CR. All spectra were
recorded in a Pharmacia Biotech Ultrospec 2000 UV/vis spec-
trophotometer, using a low volume 0.5 cm path quartz cuvette
(Hellma).
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CD
HEWL peptide aggregation, with or without polyphenols and
DMSO, was also monitored with CD using a Jasco J-810 spec-
tropolarimeter (Hachioji, Japan) equipped with a thermostatic
water bath. CD spectra from 250 to 190 nm were recorded in
HCl 10 mM at 25 ◦C with 0.15 mg/ml protein concentration, in a
0.1 cm path length cuvette (Hellma).
AFM
For the AFM analysis, HEWL or HEWL peptide samples at ThT
plateau were agitated to ensure an effective sampling of the whole
aggregated population, then they were diluted 1:100 or 1:200 in
HCl 10 mM and a 5 μl drop was laid on to a freshly cleaved mica
disc for approximately 2 min. Excess of sample was removed by
washing twice with 1 ml of bi-distilled water, then the prepara-
tion was dried with a soft nitrogen flow. AFM experiments were
performed in air, in non-contact mode, using a PicoSPM micro-
scope equipped with AAC-Mode controller (Keysight Technolo-
gies, formerly Molecular Imaging). The probes were non-contact
Silicon cantilevers (model NSG-01, NT-MDT Co., Moscow, Rus-
sia) with 150 kHz typical resonance frequency. Scanner calib-
ration was periodically checked by means of a reference grid
(TGZ02 by MikroMash) with known pitch 3 μm and step height
100 nm. Images were processed and analysed with Gwyddion
v. 2.3.4 [39].
Molecular modelling
The model amyloid core was tentatively created and refined with
Discovery Studio Viewer Pro (DSV, Accelrys), AutoDock [40]
and the Amber Molecular Dynamics suite v. 9.0 [41].
The HEWL peptide was modelled in DSV to achieve α-helix
and β-strand conformations, whereas the native conformation
was taken from the PDB structure 2VB1 [42] of the full length
HEWL (basically a β-turn-β conformation). Assemblies were
created by juxtaposing peptide monomers, previously described
as being part of the amyloid core during HEWL aggregation and
also used for the biophysical experiments detailed above.
MD
The partial atomic charges for polyphenols were derived using
the AM1-BCC method implemented in the ANTECHAMBER
suite [43]. The energy minimizations and MD were carried out
using the SANDER module of Amber 9 (University of Califor-
nia, San Francisco, USA) [41] with the GAFF [44] and ff99SB
force fields. MD simulations were performed in implicit solvent
using the generalized born surface area (GBSA) at constant pH.
The constant pH MD method has been implemented in SANDER
by Mongan et al. [45]. Before the dynamic simulation, 100 steps
of steepest-descent and 900 steps of conjugate-gradient minimiz-
ation on the entire complex were performed with a modified GB
model (igb = 2) [46], the surface area was computed and included
in the solvation term, and a cutoff of 30 ˚A for non-bonded inter-
actions was used. The system was then heated from 0 to 333 K in
5 ps by holding the complex fixed with a harmonic constraint of
strength of 0.1 kcal/mol per ˚A2. In order to equilibrate the system,
the complex was constrained with strength of 0.05 kcal/mol per
˚A2 and 50 ps dynamic simulations were performed at a constant
temperature of 333 K with SHAKE turned on for bonds involving
hydrogens, allowing a time-step of 2.0 fs. After this step, 1 ns of
dynamic simulation was performed in the same conditions. A
total of 200 snapshots, each representing a conformation, were
collected. During the simulation, every 10 snapshots a conforma-
tion was ‘minimized’ and the potential energy of the resulting 20
complexes was calculated. The gain in potential energy (En) for
each assembling starting structure type (N, H, B) was calculated
with the formula En = En − (E1 × n)/n where En is the energy
of the n assembled monomers, E1 is the energy of the monomer
and n is number of monomers.
Generation of contacts maps
Besides to final energies, MD simulations were also evaluated
in terms of frequency of contacts (dissected into van Der Waals
interaction and hydrogen bonds) of the residues in the pool of our
amyloid models. An in house script was used to extract, from Am-
ber MD results files, both distances and chemical relationships
between atoms, allowing to collect the number of interactions
thresholded at different distances during the time of simulations.
The values reported in this work comprise interactions found
at distances <3 ˚A, although shorter (stronger) interactions were
also considered. This procedure allowed to create interaction
maps indicating the most probable interaction sites. In particular,
we calculated the contact maps referred to our model β-sheets
(composed by 4 HEWL peptide, so encompassing 16 × 4 = 64
residues) when they interacted with themselves (forming the
model amyloid core) or with polyphenols and ThT.
Statistics
All mathematical and statistical processing as well as plotting and
non-linear fitting was performed with QtiPlot [47]. ThT kinetic
traces and associated errors represent the accumulation of at least
three independent experiments. CR and CD spectra as well as
AFM images are from one representative experiment.
RESULTS
HEWL and HEWL peptide aggregation kinetics
The aggregation kinetic of HEWL and HEWL peptide was mon-
itored by ThT fluorescence assay, CR assay and AFM (Figure 1).
The aggregation kinetic of the full length HEWL was previously
described by Frare et al. [11], evidencing that HEWL undergoes
X-Asp-based proteolysis when heated at acidic pH and results
in different peptides responsible for the formation of amyloid-
like fibrils. Figure 1(A) reports a typical aggregation kinetic in
our conditions monitored with ThT: we evidenced a lag phase
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Figure 2 Rosmarinic acid and resveratrol do not disturb ThT fluorescence signals
(A) Absorbance spectra of HEWL, rosmarinic acid (ROSM) and resveratrol (RESV) indicating that little or no scattering
occurs due to limited solubility of the compounds. (B) Fluorescence spectra of the same compounds excited at 440 nm,
indicating that no emission occurs at 485 nm, where ThT shows the amyloid-associated peak. (C) Fluorescence signals
of ThT pre-incubated with preformed HEWL fibrils upon the addition of rosmarinic acid and resveratrol, indicating that no
competition occurs between ThT and the tested compounds. In the latter, y-axis contains fluorescence values normalized
by ThT signal. Error bars represent the S.D. of three independent measurements.
of 2–3 days during which the enzyme fragmented (as evidenced
by SDS/PAGE, Supplementary Figure S1) and nucleated into
aggregation seeds that started an elongation phase reaching a
plateau in approximately 7–10 days. The typical HEWL peptide
aggregation kinetics was described in Krebs and co-workers [35]
as remarkably different (Figure 1E) with respect to that of full
length HEWL, lacking the lag phase and resembling an exponen-
tial curve with a plateau stabilizing after 7–10 h. In both HEWL
and HEWL peptide models the presence of cross-β structures
typical of amyloid-like aggregation was confirmed by a typical
red shift in CR assay (Figures 1B and 1F), by AFM experi-
ments (Figures 1C and 1G) and, in HEWL peptide only, by CD
(Supplementary Figure S2). HEWL fibrils collected after 300 h
incubation (largely after the begin of the ThT plateau, to ensure
reproducibility) ranged from 4 to 8.5 nm in diameter and from
0.25 to 3 μm in length, similar to those observed after 69 h incub-
ation at pH 2.0 and 57 ◦C by Arnaudov et al. [12]. HEWL peptide
fibrils showed diameters ranging from 6.0 to 8.5 nm and lengths
from 0.1 to 6.5 μm, similar to those previously reported in elec-
tronic microscopy studies [28]. All the results described above
were reproducible when 1 % or 5 % v/v DMSO was added in
the aggregation reaction, a condition met when aggregation was
performed in the presence of polyphenols (results not shown).
Polyphenol solubility and stability in experimental
conditions
Since polyphenols are known to suffer from limited solubility,
we firstly monitored this feature at 1 mM concentration, pH 2
and 65 ◦C (the conditions we used during HEWL or HEWL pep-
tide aggregation). A photometric measurement of the light scat-
tering at 600 nm evidenced that both resveratrol and rosmarinic
acid were soluble in our experimental conditions (Figure 2A).
Mass spectrometry further confirmed the chemical stability of
the molecules in the reaction conditions, evidencing that no frag-
mentation occurred during the aggregation process (results not
shown).
Effect of polyphenols on HEWL and HEWL peptide
aggregation
HEWL incubation in presence of resveratrol and rosmarinic acid
was followed by ThT assay and eventually checked by CR and
AFM at late plateau time (300 and 30 h for HEWL and HEWL
peptide respectively). ThT fluorescence evidenced that in the
presence of rosmarinic acid the signals did not grew during ag-
gregation time for either HEWL or HEWL peptide (Figures 1A
and 1E). On the contrary, control samples and samples in the
presence of resveratrol showed the typical aggregation kinetic
(sigmoid for HEWL, exponential for HEWL peptide), terminat-
ing in a plateau phase (Figures 1A and 1E). Neither resveratrol
nor rosmarinic acid proved to interfere with the fragmentation
process required to prime aggregation of HEWL (not required
for HEWL peptide), as evidenced by SDS/PAGE analysis (Sup-
plementary Figure S2). Their inhibition values were calculated as
the percent of ThT fluorescence signal with respect to untreated
controls according the plateau value obtained from fitting (Fig-
ures 1A and 1E). As reported in Table 1, rosmarinic acid showed a
marked reduction in both HEWL (83.5 +− 3.6 %) and HEWL pep-
tide (85.6 +− 10.1 %), while in both cases resveratrol proved al-
most no reduction. The AFM analysis of rosmarinic acid-treated
HEWL samples at plateau showed small particles with 1–3 nm
diameter mixed with large flat aggregates with similar height
(Figure 1D), completely different from the mature fibrils ob-
servable in aggregated HEWL controls (Figure 1C). Similarly,
HEWL peptide showed small round particles of approximately
2–3 nm in diameter (Figure 1H), completely different from fib-
rils observed in aggregated HEWL peptide controls (Figure 1G).
In order to ensure the stability of the rosmarinic acid inhibitory
effect, HEWL peptide aggregating mixture was allowed to stabil-
ize for 6 months at room temperature. AFM demonstrated that,
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Table 1 Summary of the effects of polyphenols on HEWL
and HEWL 49–64 peptide (PEPT) aggregation
Values for compounds are calculated as percentage reduction in
ThT fluorescence signals (ex. 440 nm, em. 485 nm) with respect
to plateau signals obtained by fitting of HEWL and HEWL peptide
kinetic curves.
Compound HEWL PEPT
RESV 1.9 +− 0.1 1.7 +− 0.1
ROSM 83.5 +− 3.6 85.6 +− 10.1
although HEWL alone presented long, unbranched amyloid-like
fibres, the presence of rosmarinic acid induced the formation
of nearly spherical aggregates with diameters of approximately
25–30 nm (Supplementary Figure S3), compatible with the ob-
servation that a destabilization of the cross-β structure impair
the elongation of fibrils, leading to a dramatic and stable re-
duction of the fibril burden. It is important to note that such
small particles, as well as long-term stabilized HEWL fibrils,
were non-toxic to SHSY-5Y neuroblastoma cell line (results not
shown) [48].
Polyphenols competition with ThT on preformed
fibrils
Since polyphenols are optically active molecules, due to their
aromatic rings, we evaluated possible optical artefacts in the
working conditions used for ThT assay (Figure 2). We dis-
solved both rosmarinic acid and resveratrol at 10 μM concen-
tration (the same used when in the presence of ThT for the
aggregation assay) in PBS (ThT buffer) and acquired absorb-
ance spectra in the range 400–700 nm as well as fluorescence
spectra (slit size 5 nm) in the range 460–500 nm upon excita-
tion at 440 nm (slit size 5 nm). Resveratrol did not absorb or
scatter at the tested wavelength as compared with PBS alone or
HEWL (Figure 2A). Rosmarinic acid gave a very low and broad
signal, insufficient to generate optical artefacts in fluorescence
measurements (Figure 2A). When excited at 440 nm, resveratrol
showed no emission at the tested wavelengths with respect to
both PBS alone and HEWL (Figure 2B). Rosmarinic acid gave
rise to a slight increase in emission, although very reduced with
respect to that observed for ThT (Figure 2B). These results evid-
enced that optical artefacts were not relevant in our measurement
conditions.
It is now well described that polyphenolic compounds may
compete with ThT or other amyloid probes for binding to
aggregates [49,50]. We therefore tested this feature in our aggreg-
ation conditions. We found that the ThT signals on pre-formed
HEWL fibrils were not significantly affected by rosmarinic acid
addition (signal variation − 8 %, t-test P = 0.1, n = 9) nor
by resveratrol (signal variation + 7 %, t-test P = 0.09, n = 9)
(Figure 2C). These assays, together with the optical properties
detailed above, implicitly supported the validity of using plateau
values for estimating a percentage of inhibition and also confirms
a substantial absence of competition of the tested molecules with
the ThT dye for amyloid binding.
Design of amyloid core scaffolds
In order to explain such different behaviour between rosmar-
inic acid and resveratrol we approached the problem using MD
on a reconstructed amyloid core entirely composed by HEWL
peptide monomers. To the best of our knowledge, no 3D struc-
ture is currently available for HEWL or HEWL fragments, apart
from a very short region from human lysozyme [15]. CD ana-
lysis (Supplementary Figure S4) suggested that the peptide fully
aggregates into assemblies composed by structures containing β-
sheets, with no other residual structure. Accordingly, we started
a semi-manual procedure to design different β-sheets by juxta-
posing HEWL peptide monomers in a β-strand conformation.
We tested different number of participating peptides in several
combinations of native (N, extracted from the original HEWL
crystal structure), helix (H, the most stable conformation for a
peptide in silico), or β-strand (B, involved in β-sheets and cross-β
amyloid structures) conformations. When stacking B monomers,
parallel (BP) or antiparallel (BA) directions of the strands were
evaluated, also exploring different orientation of the side chains
(namely BA1, with all side chains in the same orientation, BA2,
with side chains with alternating orientations and BAa, with en-
ergy minimized combination of orientations obtained from Auto-
Dock). For each tested structure we used molecular docking to
find favourable initial poses, then we used MD in a minimiza-
tion/heating/dynamic simulation protocol. Each result was eval-
uated in terms of total energy of the structure or energy per
monomer (see Figure 3 for a schematic representation of the
building process).
Structures likely to give rise to sheets were selected according
to two main criteria: (i) a constant relative gain in energy follow-
ing addition of monomers and (ii) an overall energy lower than
that achieved by a hypothetical assembly composed by monomers
in α-helix conformation (by far the most stable initial conforma-
tion of our 16 residue long peptide). As shown in Figure 4(A), the
gain in polymerization (normalized by the number of monomers)
usually stabilized after the addition of a 4th peptide monomer.
The most stable conformations were found to contain antiparal-
lel β-strands. In particular, the conformation showing side chains
at alternating faces (labelled as 4 × β-strand A in Figure 3),
was found to be the most stable, with a relative energy gain
of − 2166 +− 17.8 kcal/mol ( − 539.6 kcal/mol per monomer) al-
though other BA conformations were found to be acceptable.
The BP conformations were found to have energy, on average,
40 kcal/mol lower than that of the reference α-helix assembly,
and therefore such assembly was considered as energetically dis-
favoured. This result was supported by the deconvolution of CD
spectra of HEWL peptide after 46 h aggregation (Supplementary
Figure S3) performed with the BestSel server [50], indicating
a 57 % of antiparallel β-sheets and almost no signal of parallel
β-sheets (preliminary result). It is noticeable to observe that the
ensemble built-up by strands in a conformation similar to that
observed in the original, full-length HEWL, showed to be the
less stable among the tested conformations.
A core fibril packaging was then built by imposing a face-to-
face interaction between identical pairs of the three isomers of
tetrameric β-sheets using MD to estimate the total energy. At this
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Figure 3 Scheme of the building of the amyloid core model and proposed MD-based inhibition assay strategy
Top row: three monomeric conformations were initially built using DSV, namely β -strand, α-helix and native (obtained from
HEWL taken from the PDB structure 2VB1 [35]). Middle row: the quaternary structure assembly was simulated by adding
monomers one by one using AutoDock. α-Helix and native assemblies were used for energy references, verifying that all
β -sheets conformations presenting alternating or in phase orientations of side chains were energetically favoured. Bottom
row: two juxtaposed β -sheets gave rise to the amyloid core model. Its energy was compared with that obtained by the
addition of polyphenols (ROSM, rosmarinic acid and RESV, resveratrol) or ThT to investigate their ability to compete with
fibril formation.
stage, the BP-based β-sheet was also evaluated to verify that this
configuration was disfavoured also in the core fibril structure. Ten
initial conformations for each pairing were semi-manually posed
and then analysed by MD. We found that all antiparallel β-sheets
paired with an energy 100 kcal/mol lower, on average, than par-
allel β-sheets (Figure 4B). Pairs of antiparallel conformations,
although arising from different β-sheets, were found to stabil-
ize in a number of conformations with relatively similar energy
(within 1 % each other), indicating that several types of fibrils,
equally likely, could be formed. This led to a definitive pool of
stable conformations, with energy gains with respect to separated
β-sheets of − 26 +− 25, − 65 +− 25 and − 28 +− 25 kcal/mol for
the BAa, BA1 and BA2 conformations, respectively, as reported
in Table 2.
This pool was then used as a set of possible amyloid cores
to be used as a testing ground for MD studies on resveratrol
and rosmarinic acid as negative and positive effector in amyloid
inhibition respectively. The path used to build the amyloid core
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Figure 4 Initial building of the amyloid core model: potential
free energies associated to various types of HEWL peptide
assemblies
Identical monomers in three different starting conformations, namely
native (minimized with no constrains), α-helix or β -strand, were allowed
to stack and interact to form an initial sheet. The accumulation of up to
five monomers were followed my MD resulting in six different types of
stacks: N (native stack), H (helix stack), BP (all-parallel β -stack), BAa
(alternate antiparallel β -stack, minimized orientation of side chains),
BA1 (alternate antiparallel β -stack, all side chains in the same direc-
tion) and BA2 (alternate antiparallel β -stack, all side chains in opposite
directions). See the figure for a graphical visualization of the structures
with four monomers, generally resulting as stabilized in terms of gain
in energy. (A) Potential energy (Ep) of the assembling structures; (B)
variation of potential energy (Ep) during the assembly.
model, as well as the energies resulting from MD, is depicted
in Figure 3. From the analysis of hydrogen bond contact maps
(Figure 5), obtained by counting the number of hydrogen bonds
occurring between interacting side chains of paired sheets (pool)
during the MD simulation, it emerged that the residue Arg13 of
each strand is the major responsible of the stabilization of the
model amyloid core, with minor contributions of Asp4 and Trp14
of the strand A, Gln9 of the strands B and C and Asn11 of the strand
Table 2 Summary of the energies observed during the
design of the amyloid core model
Epβ -sheet: potential energy of a β -sheet composed by four strands.
Epcore: potential energy of the cross-β fibril core composed by two
β -sheets containing four strands each. Epcore: potential energy
gain associated to β -sheet assembly into the amyloid core, cal-
culated with the formula Epcore = Epcore − 2 × Epβ -sheet. Labels
are as follows: BP (all-parallel β -stack), BAa (alternate antiparal-
lel β -stack, minimized orientation of side chains), BA1 (alternate
antiparallel β -stack, side chains in the same direction) and BA2
(alternate antiparallel β -stack, side chains in opposite directions).
All values are expressed as kcal/mol.
β-Sheet type Epβ-sheet Epcore Epcore
BP − 2074 +− 18 − 4211 +− 25 − 63 +− 22
BAa − 2137 +− 18 − 4300 +− 35 − 26 +− 25
BA1 − 2121 +− 18 − 4307 +− 36 − 65 +− 25
BA2 − 2166 +− 18 − 4359 +− 35 − 28 +− 25
BA (avg) − 2141 − 4322 − 40
C. The van der Waals interaction maps (computed as for hydrogen
bonds) further indicated a relevant contribution of the internal
hydrophobic region (from Ile7 to Ile10) to the stabilization of the
assembly (Figure 6). This core interaction spanning positions 7–
10 was also confirmed by the consensus amyloid server prediction
AmylPred2 [51], as shown in Supplementary Figure S5.
MD of polyphenol interaction with growing β-sheets
AutoDock and MD (1 ns) were used to establish the binding
energy and the most probable conformation(s) for the binding of
polyphenols to peptide monomers in order to evaluate whether
a competition could occur during the initial formation of the
β-sheet.
The energy gain obtained by binding to rosmarinic acid
or resveratrol was related to the concentration of polyphenols
used. The stoichiometry ratios (peptide/polyphenol) used for the
experimental measure was of 1:1. At stoichiometry ratios of
1:4 peptide/polyphenol the calculated energy gain was 12 and
19 kcal/mol for rosmarinic acid and resveratrol respectively. In
both cases, energy gains were largely not sufficient to compete
with the addition (stacking) of a new monomer (45–50 kcal/mol)
required for the initial formation of the β-sheet (Figure 3). Such
data suggested that a mechanism of inhibition based on an impair-
ment of the formation of the β-sheet by blocking β-strand stack-
ing should be excluded. In addition, the initial, most favourable,
docking position from AutoDock indicated that both polyphenols
did not form hydrogen bonds with atoms of the backbone, that
primarily drive the association of protein secondary structure, but
rather they interacted with side chains in orientations that did not
obstacle the stacking of the strands.
MD of polyphenol interaction with amyloid core
MD was then used to study the binding of polyphenols to the
model amyloid core. Polyphenols were added for docking (at
stoichiometry ratios of 1:1peptide/polyphenol) into preformed
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Table 3 Potential energy associated to amyloid inhibition
Values represent the average gain in binding energy of test com-
pounds to all the β -sheet of the model amyloid cores. For reference,
the most favourable addition of second β -sheet (generating the full
core), involved an average energy gain of − 40 kcal/mol. All values
are expressed as kcal/mol.
Compound Epcore
RESV − 26 +− 19
ROSM − 59 +− 19
ThT − 33 +− 19
4-strand β-sheets to determine favourable initial poses, and then
a 1 ns MD simulation was run.
In both cases, as expected from previous results, AutoDock
determined that the best binding positions involved interactions
with specific side chains and not with backbone atoms (Figure 3,
bottom row). MD indicated that the energy gain in having ros-
marinic acid bound on a side of the β-sheet is more than double
than that of having resveratrol. The average values obtained from
the bound between the three types of preformed 4-strand β-sheets
(described above), were − 59 kcal/mol for rosmarinic acid and
− 26 kcal/mol for resveratrol. Considering that the average value
obtained by the addition of two 4-strand β-sheet (as in the form-
ation of the model amyloid core described above) involved an
energy gain of − 40 kcal/mol, it was reasonable to conclude that
rosmarinic acid, but not resveratrol, was able to compete with
the formation of the cross-β structure (Table 3). The analysis
of hydrogen bond maps also confirmed this stronger interaction.
In fact, rosmarinic acid was found to frequently form hydrogen
bonds with the side chains of the β-sheets (5788 times for all
models types during the simulation time, lower but comparable
with the 6457 contacts of the sheet-to-sheet interaction in the
amyloid core model detailed above), most noticeably with Thr3
of the A strand, Arg13 of the A and D strands and Trp15 of the A
strand, plus a general preference for the 11–16 region (Figure 5B).
No interaction was observed with backbone atoms. Resveratrol
was also found not to bind backbone atoms. In addition, it showed
only 2012 hydrogen bonds formed with the preformed β-sheet
for all model types (during the 1 ns simulation), preferentially
with Thr3 of the A strand Trp14 of A and D strands. Such posi-
tions were not involved in the stabilization of the amyloid core,
thus reinforcing the observation that resveratrol is ineffective in
inhibiting amyloid aggregation.
Taken together, the results showed a clear agreement to what
experimentally observed using all the amyloid probes and spec-
troscopic investigations, indicating that the MD approach we set
up was effective in shedding lights into the molecular mechanism
of amyloid inhibition by rosmarinic acid both in HEWL peptide
or in the full length HEWL from which the extracted peptide was
described as a major constituent of the amyloid core [11].
Polyphenols does not compete with ThT for the
amyloid core
Simulations similar to that used for polyphenols were also
performed using ThT as a ligand. MD results indicated that ThT
Figure 5 Hydrogen bond maps
Hydrogen bond maps of our model 4-stranded β -sheet interacting with
(A) a second, identical model β -sheet, (B) rosmarinic acid or (C) res-
veratrol. The positions of the interacting residues are reported in the
x-axis (referred to a single monomeric 49–64 HEWL peptide) and the
number of hydrogen bonds found during MD simulation by the interact-
ing element (estimated at a distance within 3 A˚) are reported on the
y-axis. The four strands of the β -sheet are indicated by circles, squares,
diamonds and triangles for strands A, B, C and D respectively.
interacted with the β-sheet with an energy intermediate
between rosmarinic acid and resveratrol ( − 33 kcal/mol, average
value for three types of preformed 4-strand β-sheets described
above), indicating a possible inhibitory effect, at least at the
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Figure 6 van der Waals interaction maps
van der Waals interaction maps of our model 4-stranded β -sheet inter-
acting with (A) a second, identical model β -sheet, (B) ThT, (C) rosmarinic
acid or (D) resveratrol. The positions of the interacting residue are repor-
ted in the x-axis (referred to a single monomeric 49–64 HEWL peptide)
and the number of van der Waals interactions found during MD simula-
tion by the interacting element (estimated at a distance within 2.3 A˚)
are reported on the y-axis. The four strands of the β -sheet are indicated
by circles, squares, diamonds and triangles for strands A, B, C and D
respectively.
tested stoichiometry. Nevertheless, the interaction maps
were found to be completely different with respect to those of
rosmarinic acid. Of primary importance, ThT proved not to form
hydrogen bonds with the amyloid core. When van der Waals
interaction were monitored, ThT showed a broader spectrum of
contacted residues and an overall higher number of interactions
with respect to polyphenols (11454 total contacts for all model
types compared with 8674 and 7260 for rosmarinic acid and
resveratrol, respectively, in the whole 1 ns MD simulation), as
shown in Figure 6. Such difference was found to be mostly
related to contacts in the central hydrophobic region of the
strands, almost completely neglected by polyphenols. This result
was in agreement with the experimental evidence concerning
the competition of polyphenols with ThT for amyloid binding
(Figure 2). In fact, the addition of rosmarinic acid on preformed
HEWL amyloid fibrils previously bound with ThT was observed
to have a very limited competition effect. Such competition,
that is currently regarded as a major confounding evidence in
amyloid research [49,50], has for long time being neglected,
seriously compromising the interpretation of inhibition effects.
DISCUSSION
In the current study we managed to explain, using MD, the dif-
ferent behaviour of two polyphenols, rosmarinic acid and res-
veratrol, on amyloid aggregation of HEWL upon heat-induced
acid fragmentation. We demonstrated that the two molecules
display extremely different effects on amyloid aggregation, the
former being highly inhibitory, the latter completely inactive.
Since we wanted to study such properties using computational
techniques we had to face two different problems: (i) the absence
of a reference structure to use as a model and (ii) the need of a
model that is simple enough in terms of participating atoms, to
be fully evaluated in MD. Both problems were overridden by the
use of the well described amyloidogenic 49–64 HEWL peptide
(16 AA long), after a preliminary experimental verification that
all the results obtained with full length HEWL applied to this
simplified model.
To the best of our knowledge, no 3D structure of amyloid ag-
gregates of HEWL is available or suitable to our needs. HEWL
was found to form spherical aggregates (spherulites) large in dia-
meter and composed by an isotropic assembly of 1–2 μM fibrils.
Such structures were observed in several other amyloidogenic
proteins [52] and are hard to study by morphological techniques
such as TEM or AFM. The work of Yagi et al. [53] using mi-
crobeam X-ray diffraction on fibrils from full-length HEWL sug-
gested conformations that did not encompass the well described
[11] amyloidogenic 49–64 region we used in MD and biophys-
ical experiments. Little hints were also attainable by the work
of Zou et al. [54], describing that HEWL aggregates may exist
in both parallel and antiparallel β-sheet conformation leading or
not to productive fibril assembly, depending on the experimental
conditions.
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Since we did not have a reference structure of HEWL amyloid,
we chose to use a supervised approach to build a model amyl-
oid core ab initio. To this aim, we followed three fairly naı¨ve
assumptions: (i) the internal structure of amyloid is a β-sheet;
(ii) cross-β interactions are at the basis of amyloid; (iii) the ag-
gregation follows a path in which monomers build up sheets and
then sheets assembled into fibrils. Such simplified assumptions
were found to give energetically robust results, evidencing at least
three important considerations.
First, we found that the formation of the β-sheet was favoured
until a 4th strand stacked, the addition of a 5th sheet not giving
a supporting gain of energy. This is consistent with the current
knowledge on protein structures, that were not generally ob-
served with extended sheets, apart from functional or structural
specificities such as in silk fibroin [55] due to unfavourable di-
hedral angles that impose a twist in the sheet and therefore a
limitation in planarity of the resulting structure. This result is
also supported by the aforementioned work by Zou et al. [54],
describing that HEWL aggregates formed at lower temperatures
are populated by off-pathway oligomers with antiparallel con-
formations. We may speculate that our model (that we termed
model amyloid core) is representative of an initial assembly that
is not sufficiently stable to elongate into fibrils and whose form-
ation can be effectively hampered by the addition of exogenous
compounds.
Secondly, we found that the face-to-face packing of a second
sheet further stabilized the overall structure, favouring the form-
ation of the cross-β structure typical of amyloid. In this set-
up, interdigitated side chains builds up a zipper that confers
planarity to both strands, thus favouring the formation of the
assembly.
Thirdly, we found that β-sheets formed by antiparallel strands
were relatively more stable than those obtained from parallel
strands. This is not in contrast with the vast majority of literat-
ure on disease-related proteins, reporting that amyloid is built-up
by parallel, frequently in register β-sheets [56]. In fact, peptides
containing a single β-strand more frequently forms fibrils using
an antiparallel conformation, supporting the idea that short pep-
tides extracted from the main chain are more frequently found in
antiparallel conformation, whereas full peptides containing two
strands are more stable in a parallel conformation [56]. Examples
of fibrils with antiparallel configurations are largely documented,
such as the NFGAIL fragment of IAPP [57], the D23N IOWA
mutant of Aβ1–40 [58], or series of small aggregating fragments
from the Aβ peptide containing amyloid strands [59–62]. On
the other hand, the amyloid core of HEWL, among others, was
recently investigated for the construction of novel nanomaterials
[15]. The human sequence IFQINS (corresponding to ILQINS in
HEWL), described as the most aggregation prone, was allowed to
self-assemble into fibrils ad then crystals were resolved by X-ray
crystallography, revealing the stacking of zipped β-sheets with
a parallel orientation of the β-strands. The authors claimed that
such structure was largely the most stable. From our simulation
studies, an antiparallel orientation of the β-strands resulted the
most probable, and the more likely to form fibrils from the HEWL
peptide 49–64. Although dissonant, the two results are not to be
considered in disagreement for at least two reasons: (i) the length
of the IFQINS peptide (6 AA) that can form a highly stable hy-
drophobic zipper structure with no interference by surrounding
residues and (ii) the absence of charged residues that do not intro-
duce electrostatic effects in the overall structure. The consensus
amyloid stretch predictor AmylPred assigned to a short region
spanning positions 7–10 a high propensity to form the typical
amyloid zipper, but the parallel conformation of the sheets would
be disfavoured by the residues Asp4 and Arg12 flanking such re-
gion. On the contrary, an antiparallel orientation favoured both
the hydrophobic interactions in the zipper and the electrostatic
interactions between polar and charged residues. Indeed, it has
been demonstrated that the nature and conformation of amyloid
structures are largely variable and highly depend on the sequence
length, composition and other peculiar features, as reviewed by
Sawaya et al. [63].
As evaluated by MD, we found that the association energies
between ligands and elements of the model amyloid β-core could
easily explain their overall effect on aggregation. The energies of
1:1 binding of a single β-strand with itself or with resveratrol and
rosmarinic acid was clearly in favour of the β-sheet growth. This
held true also when the ratio of strand:polyphenol was tested at
1:4, meaning that the formation of β-sheets could not be blocked
by the addition neither of rosmarinic acid nor of resveratrol.
What could rosmarinic acid (not resveratrol) do was indeed to
compete with the pairing of two sheets. In a monomer:polyphenol
1:1 stoichiometry, the energy associated to rosmarinic acid inter-
action was comparable to that of a second sheet, whereas that
of resveratrol was found to be much lower. Accordingly, a true
competition might occur only with rosmarinic acid, that is what
experimental data suggested. Using the energy gain of β-sheets
self-assembly in model amyloid core as a cut-off and the over-
all hydrogen bond mapping, we could rationalize that molecules
that do not bind to single β-sheets with an energy comparable
to that of self-assembly or bind at positions not involved in the
same stabilizations of the paired sheets, could be considered as
unlikely to give inhibitory effects.
Although our results suggest our method as a potential predic-
tion tool (e.g. by ranking the testing compounds by a combina-
tion of binding energy and position), we tend not to encourage
such perspective but rather to suggest to use the model as a
rule of thumb for calling as inhibitory a molecule that have an
energy higher or at least comparable to that of the model amyl-
oid core, provided that the contact maps, in terms of hydrogen
bonds, is comparable. Nevertheless, examples have been docu-
mented of molecules that, upon binding, have the unpredictable
(and undesirable) behaviour of favouring aggregation due to an
ordering effect. As an example, a recent work on Aβ (1–40) pep-
tide reports that ThT can be a promoter of aggregation, rather
than an inhibitor as its well-known binding capability may have
suggested [64].
Since we found that the energy associated to β-sheet stack-
ing is hard to be competed, due to the network of hydrogen
bond interactions between backbone atoms of the strands, the
inhibitory effect should, in general, be searched in the ham-
pering of the β-sheet pairing through strong interactions with
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side chains. This can unequivocally lead to the conclusion that,
as the sequences of amyloid cores varies widely among the
different amyloid system known so far, although rationalized
by several observations and algorithms [65,66], there must be
an extreme specificity in finding good inhibitors for different
proteins.
Our future work will be aimed at generating amyloid core
models for different amyloid related proteins and testing our
system in additional situations with respect to those performed
in this pilot work. In particular, we will use, where avail-
able, the proposed crystals of fibrils as the starting ground
for the building of the computational framework. When not
available, we will use the wealth of computational methods
developed to identify amyloidogenic regions in protein se-
quences to do a de novo building and further verify whether
this approach is feasible in other different and less described
contexts.
CONCLUSION
In this work we have developed a strategy for the study and
the characterization of small molecule interaction with amyloid-
related proteins. Although several structural assumptions were
made (taking into account literature and protein structure the-
ories), our results were fully supported by experimental data.
Our computational framework can describe the effect of a small
ligand on HEWL peptide from two different perspectives, both
related to amyloidogenicity, i.e. (i) the competition with β-sheet
elongation or (ii) the competition with β-sheet association. Both
activities play a pivotal role in amyloid development and may
give rise to different effects. Our results supported our general
strategy of considering as equally likely structures derived from
a pool of conformations rather than just the most stable one,
and computing binding energies as the result of an association
between such pooled constituents. The strategy introduced in this
work represents an initial step towards the ability of rationalizing
the effects of drugs aimed at inhibiting and preventing amyl-
oid deposits, giving new insights into the development of new,
rationally designed, anti-amyloid drugs.
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